HGH Holdings Ltd. (SGX: 5GZ)
Singapore
· Delayed Price · Currency is SGD 0.0130
0.00 (0.00%)
At close: Sep 11, 2024
HGH Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 17.46 | 20.03 | 21.59 | 20.07 | 11.7 | 23.9 | Upgrade
|
| Revenue Growth (YoY) | -22.33% | -7.20% | 7.56% | 71.60% | -51.06% | 21.98% | Upgrade
|
| Cost of Revenue | 12.93 | 16.25 | 17.75 | 15.52 | 8.04 | 14.89 | Upgrade
|
| Gross Profit | 4.54 | 3.78 | 3.84 | 4.55 | 3.65 | 9.01 | Upgrade
|
| Selling, General & Admin | 5.49 | 5.49 | 6.25 | 5.99 | 5.89 | 8.53 | Upgrade
|
| Other Operating Expenses | 0.01 | 0.01 | 0.11 | 0.94 | 0.94 | 0.92 | Upgrade
|
| Operating Expenses | 5.43 | 5.43 | 6.21 | 7.26 | 7.22 | 9.22 | Upgrade
|
| Operating Income | -0.9 | -1.65 | -2.38 | -2.71 | -3.57 | -0.21 | Upgrade
|
| Interest Expense | -0.15 | -0.16 | -0.17 | -0.17 | -0.18 | -0.33 | Upgrade
|
| Interest & Investment Income | 0.13 | 0.13 | - | - | - | 0.18 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.04 | -0.04 | -0.05 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.69 | 1.08 | 0.59 | 0.36 | 0.69 | -3.9 | Upgrade
|
| EBT Excluding Unusual Items | -0.27 | -0.64 | -2 | -2.52 | -3.06 | -4.27 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -2.51 | -1.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.13 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.03 | 0.03 | 0.22 | 0.14 | -0 | -0.07 | Upgrade
|
| Asset Writedown | - | - | - | -1.01 | - | -0.52 | Upgrade
|
| Other Unusual Items | - | - | - | 0.37 | 0.89 | - | Upgrade
|
| Pretax Income | -0.24 | -0.61 | -1.78 | -3.02 | -4.81 | -5.89 | Upgrade
|
| Income Tax Expense | -0.16 | -0.28 | -0.27 | -0.73 | -0.56 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | -0.08 | -0.32 | -1.51 | -2.29 | -4.25 | -5.93 | Upgrade
|
| Net Income to Company | -0.08 | -0.32 | -1.51 | -2.29 | -4.25 | -5.93 | Upgrade
|
| Minority Interest in Earnings | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Net Income | -0.06 | -0.31 | -1.5 | -2.27 | -4.24 | -5.9 | Upgrade
|
| Net Income to Common | -0.06 | -0.31 | -1.5 | -2.27 | -4.24 | -5.9 | Upgrade
|
| Shares Outstanding (Basic) | 1,876 | 1,781 | 1,781 | 1,781 | 1,781 | 1,781 | Upgrade
|
| Shares Outstanding (Diluted) | 1,876 | 1,781 | 1,781 | 1,781 | 1,781 | 1,781 | Upgrade
|
| Shares Change (YoY) | 6.95% | - | - | - | 0.00% | -23.94% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 0.01 | 2.71 | -0.3 | 1.75 | 0.74 | 9.44 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Gross Margin | 25.97% | 18.87% | 17.77% | 22.69% | 31.23% | 37.69% | Upgrade
|
| Operating Margin | -5.14% | -8.23% | -11.00% | -13.50% | -30.50% | -0.87% | Upgrade
|
| Profit Margin | -0.37% | -1.53% | -6.97% | -11.32% | -36.22% | -24.70% | Upgrade
|
| Free Cash Flow Margin | 0.05% | 13.53% | -1.41% | 8.70% | 6.31% | 39.49% | Upgrade
|
| EBITDA | 2.69 | 1.93 | 1.32 | 1.76 | 0.94 | 4.08 | Upgrade
|
| EBITDA Margin | 15.43% | 9.61% | 6.10% | 8.78% | 8.03% | 17.08% | Upgrade
|
| D&A For EBITDA | 3.59 | 3.57 | 3.69 | 4.47 | 4.51 | 4.29 | Upgrade
|
| EBIT | -0.9 | -1.65 | -2.38 | -2.71 | -3.57 | -0.21 | Upgrade
|
| EBIT Margin | -5.14% | -8.23% | -11.00% | -13.50% | -30.50% | -0.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.